GLP-1 agonists , or glucagon-like peptide-1 substances, are emerging as a remarkable breakthrough in treating type 2 diabetes . These innovative therapies work by increasing insulin release and inhibiting https://glp-1552097.blogdigy.com/glp-1-a-promising-approach-in-glucose-treatment-67418652